Transaction · 0000950170-25-003533

Klee Justin B.

Klee Justin B., CEO, reported an open-market or private sale at Amylyx Pharmaceuticals, Inc. involving 7471.000000 shares for an estimated $30201.52. Reported holdings after the transaction were 3176788.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
AMLXAmylyx Pharmaceuticals, Inc.
Filing timeJan 08
Trade dateJan 06, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AMLX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AMLX since 2025-01-08Filed 603 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-003533
Common Stock
Transaction date
Jan 06, 2025
Filed Jan 08, 2025, 10:29 PM · 2d delay
Shares
7.47k sh
$404 per share
Estimated value
-$3.02M
Computed from shares × price
Holdings after
3.17M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Co-Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the di…

  2. F2

    The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.99 to $4.09. Full information regarding the number of shares sold at…

Original filing · 0000950170-25-003533
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AMLX